A retrospective study evaluating the effect of trastuzumab addition to carboplatin/paclitaxel on overall survival in patients with advanced-stage HER2/neu-overexpressing uterine serous carcinoma or carcinosarcoma

Authors: Ting-Fang Lu, Lou Sun, Yu-Hsiang Shih, Yen-Fu Chen, Chun-Ting Fan, Shao-Jing Wang, Shih-Tien Hsu, Chih-Ku Liu, Sheau-Feng Hwang, Chien-Hsing Lu

Source: BMC Medicine, Vol 23, Iss 1, Pp 1-9 (2025)

Subject Terms: Uterine serous carcinoma, Uterine carcinosarcoma, Human epidermal growth factor receptor 2, Trastuzumab, Medicine

File Description: electronic resource

Relation: https://doaj.org/toc/1741-7015

Access URL: https://doaj.org/article/ee690722b4ca4df79b90c716dbd214b7

Concordance of HER2 Expression in Paired Primary and Metastatic Sites of Endometrial Serous Carcinoma and the Effect of Intratumoral Heterogeneity

Authors: Francis Hong Xin Yap, Yancey Wilson, Joanne Peverall, Benhur Amanuel, Ben Allanson, Sukeerat Ruba

Source: Journal of Molecular Pathology, Vol 5, Iss 3, Pp 405-414 (2024)

Subject Terms: endometrial serous carcinoma, HER2, metastasis, uterine serous carcinoma, Pathology, RB1-214

File Description: electronic resource

Relation: https://www.mdpi.com/2673-5261/5/3/27; https://doaj.org/toc/2673-5261

Access URL: https://doaj.org/article/4655c893ad04415ebf49bebb78407a6c

Updates and controversies in the management of uterine serous carcinoma and uterine carcinosarcoma

Authors: Toboni, Michael ^a, Kurnit, Katherine ^b, Erickson, Britt ^c, Powell, Matthew ^d, Secord, Angeles Alvarez ^e, Fader, Amanda N. ^{f, ⁎}

Source: In International Journal of Gynecological Cancer March 2025 35(3)

Germline genetic testing reveals pathogenic variants in uterine serous carcinoma patients

Authors: Katelyn Tondo-Steele, Kara J. Milliron, Jean H. Siedel, Shitanshu Uppal, Sofia D. Merajver, Karen McLean

Source: Gynecologic Oncology Reports, Vol 55, Iss , Pp 101498- (2024)

Subject Terms: Genetic testing, Genetic counseling, Pathogenic variant, Uterine serous carcinoma, BRCA, Gynecology and obstetrics, RG1-991, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2352578924001772; https://doaj.org/toc/2352-5789

Access URL: https://doaj.org/article/11d9ba34d5b74130af7c5cd8e3b416cd

The comparison of pure uterine serous carcinoma and mixed tumor with serous component: a single-institution review of 91 cases

Authors: Xuewu You, Yangyang Dong, Jiaqi Wang, Yuan Cheng, Yuanyuan Jia, Xiaobo Zhang, Jianliu Wang

Source: BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)

Subject Terms: Uterine serous carcinoma, Mixed tumor, Histological type, Progression-free survival, Overall survival, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2407

Access URL: https://doaj.org/article/6b98c6f299cb4a2fb041dfbdcf5b23cd

HER2-Positive Serous Endometrial Cancer Treatment: Current Clinical Practice and Future Directions

Authors: Dimitrios Papageorgiou, Galateia Liouta, Ioakeim Sapantzoglou, Eleftherios Zachariou, Dimitra Pliakou, Katerina Papakonstantinou, Theofanis Floros, Evangelia Pliakou

Source: Medicina, Vol 60, Iss 12, p 2012 (2024)

Subject Terms: endometrial cancer, serous endometrial cancer, HER2, HER2-directed therapy, HER2-positive uterine serous carcinoma, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.mdpi.com/1648-9144/60/12/2012; https://doaj.org/toc/1010-660X; https://doaj.org/toc/1648-9144

Access URL: https://doaj.org/article/c1c8f9420714464a8d1267b48f4969ce

Ipatasertib, an oral AKT inhibitor, in combination with carboplatin exhibits anti-proliferative effects in uterine serous carcinoma

Authors: Wesley C. Burkett, Ziyi Zhao, Meredith A. Newton, Wenchuan Sun, Boer Deng, Angeles Alvarez Secord, Chunxiao Zhou, Victoria Bae-Jump

Source: Annals of Medicine, Vol 55, Iss 1, Pp 603-614 (2023)

Subject Terms: Ipatasertib, apoptosis, invasion, synergy, carboplatin, uterine serous carcinoma, Medicine

File Description: electronic resource

Relation: https://doaj.org/toc/0785-3890; https://doaj.org/toc/1365-2060

Access URL: https://doaj.org/article/ecb88b1b26b24a17813aa38f363d5220

Comparison of clinical characteristics and prognosis in endometrial carcinoma with different pathological types: a retrospective population-based study

Authors: Gong Zhang, Fangfang Nie, Weinan Zhao, Pin Han, Jing Wen, Xiaoran Cheng, Weijia Wu, Qianwen Liu, Yi Sun, Yuanpei Wang, Yuchen Liu, Fang Ren

Source: World Journal of Surgical Oncology, Vol 21, Iss 1, Pp 1-11 (2023)

Subject Terms: Endometrial carcinoma, Uterine endometrioid carcinoma, Uterine serous carcinoma, Uterine mixed carcinoma, Uterine clear cell carcinoma, Prognosis, Surgery, RD1-811, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1477-7819

Access URL: https://doaj.org/article/007746a23b8b4407b449b4be53229f91

Oxidative stress‐induced FAK activation contributes to uterine serous carcinoma aggressiveness

Authors: Isabel C. Lopez‐Mejia, Jordi Pijuan, Raúl Navaridas, Maria Santacana, Sònia Gatius, Ana Velasco, Gerard Castellà, Anaïs Panosa, Elisa Cabiscol, Miquel Pinyol, Laura Coll, Núria Bonifaci, Laura Plata Peña, August Vidal, Alberto Villanueva, Eloi Gari, David Llobet‐Navàs, Lluis Fajas, Xavier Matias‐Guiu, Andrée Yeramian

Source: Molecular Oncology, Vol 17, Iss 1, Pp 98-118 (2023)

Subject Terms: focal adhesion kinase, migration, reactive oxygen species, uterine serous carcinoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1574-7891; https://doaj.org/toc/1878-0261

Access URL: https://doaj.org/article/f663469d36c74406919fb1ffb516ab40

Neoadjuvant chemotherapy in patients with stage IVB uterine serous carcinoma: a Turkish multicentric study

Authors: Mehmet Unsal, Cigdem Kilic, Caner Cakir, Fatih Kilic, Burak Ersak, Sema Karakas, Nedim Tokgozoglu, Bulut Varli, Okan Oktar, Gunsu Kimyon Comert, Isa Aykut Ozdemir, Nurettin Boran, Tayfun Toptas, Isin Ureyen, Vakkas Korkmaz, Salih Taskin, Ozlem Moraloglu Tekin, Yaprak Ustun, Tolga Tasci, Firat Ortac, Taner Turan

Source: Journal of Obstetrics and Gynaecology, Vol 43, Iss 1 (2023)

Subject Terms: neoadjuvant chemotherapy, advanced stage, uterine serous carcinoma, survival, Gynecology and obstetrics, RG1-991

File Description: electronic resource

Relation: https://doaj.org/toc/0144-3615; https://doaj.org/toc/1364-6893

Access URL: https://doaj.org/article/649203dfaeb74bdfa6b5c6b2a3948fd9

Trastuzumab deruxtecan in recurrent uterine serous carcinoma resistant to trastuzmab based-chemotherapy

Authors: Blair McNamara, Stefania Bellone, Cem Demirkiran, Tobias Max Philipp Hartwich, Alessandro D. Santin

Source: Gynecologic Oncology Reports, Vol 48, Iss , Pp 101219- (2023)

Subject Terms: Trastuzumab deruxtecan, DS-8201a, Uterine serous carcinoma, HER2/neu, Gynecology and obstetrics, RG1-991, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2352578923000887; https://doaj.org/toc/2352-5789

Access URL: https://doaj.org/article/65f35d1815de4ce1953b17e0506522e9

The role of lymphadenectomy in patients with stage III&IV uterine serous carcinoma: Results of multicentric Turkish study

Authors: Cakir, Caner ^a, Kilic, Fatih ^{b, ⁎}, Kilic, Cigdem ^a, Tokgozoglu, Nedim ^c, Ersak, Burak ^b, Ayhan, Sevgi ^b, Akar, Serra ^b, Yuksel, Dilek ^a, Korkmaz, Vakkas ^a, Boran, Nurettin ^a, Toptas, Tayfun ^d, Kimyon Comert, Gunsu ^b, Ureyen, Isin ^d, Tasci, Tolga ^c, Turkmen, Osman ^b, Moraloglu Tekin, Ozlem ^b, Ustun, Yaprak ^a, Turan, Taner ^b

Source: In Journal of Gynecology Obstetrics and Human Reproduction May 2021 50(5)

A 4-gene signature predicts prognosis of uterine serous carcinoma

Authors: Hui Chen, Lingjun Li, Ping Qin, Hanzhen Xiong, Ruichao Chen, Minfen Zhang, Qingping Jiang

Source: BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)

Subject Terms: Uterine serous carcinoma, Biomarkers, Signature, Mortality, Recurrence, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2407

Access URL: https://doaj.org/article/4635703ad412481cb877fcf1b0a01ad4

Abdominopelvic Metastasis of Endometrial Serous Carcinoma Initially Misdiagnosed as Early-Stage Low-Grade Endometrioid Carcinoma: The Importance of Recognizing Minimal Uterine Serous Carcinoma

Authors: Jiheun Han, Hyun-Soo Kim

Source: Case Reports in Oncology, Vol 13, Iss 3, Pp 1537-1544 (2020)

Subject Terms: endometrium, minimal uterine serous carcinoma, endometrioid carcinoma, metastasis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.karger.com/Article/FullText/511701; https://doaj.org/toc/1662-6575

Access URL: https://doaj.org/article/0d7cb138dad94500a3fcf08b2eb2f12a

Utility of a custom designed next generation DNA sequencing gene panel to molecularly classify endometrial cancers according to The Cancer Genome Atlas subgroups

Authors: Eirwen M. Miller, Nicole E. Patterson, Gregory M. Gressel, Rouzan G. Karabakhtsian, Michal Bejerano-Sagie, Nivedita Ravi, Alexander Maslov, Wilber Quispe-Tintaya, Tao Wang, Juan Lin, Harriet O. Smith, Gary L. Goldberg, Dennis Y. S. Kuo, Cristina Montagna

Source: BMC Medical Genomics, Vol 13, Iss 1, Pp 1-14 (2020)

Subject Terms: Endometrial carcinoma, Uterine serous carcinoma, Endometrioid uterine carcinoma, Next generation sequencing, Genomic profiling, Molecular groups, Internal medicine, RC31-1245, Genetics, QH426-470

File Description: electronic resource

Relation: https://doaj.org/toc/1755-8794

Access URL: https://doaj.org/article/33a0b4284a8643d588a9d184404e3e34

Oncological Safety of Diagnostic Hysteroscopy for Apparent Early-Stage Type II Endometrial Cancer: A Multicenter Retrospective Cohort Study

Authors: Hui Zhou, Kai-Fa Lai, Qian Xiang, Yu Xu, Qian-Wen Zhang, Cui Hu, Xi-Guang Mao, Cheng Chen, Wu Huang, Gong-Sheng Mi, Juan Shen, Yong Tian, Feng-Mei Ke

Source: Frontiers in Oncology, Vol 12 (2022)

Subject Terms: uterine serous carcinoma, uterine clear cell carcinoma, diagnostic hysteroscopy, overall survival, disease-free survival, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2022.918693/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/2c786d3a23f24090aabecdd385f0d52c

A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma

Authors: Elizabeth H. Stover, Niya Xiong, Andrea P. Myers, Nabihah Tayob, Victoria Engvold, Madeline Polak, Russell R. Broaddus, Vicky Makker, Ronny Drapkin, Joyce F. Liu, Neil S. Horowitz, Funda Meric-Bernstam, Carol Aghajanian, Robert L. Coleman, Gordon B. Mills, Lewis C. Cantley, Ursula A. Matulonis, Shannon N. Westin, Panagiotis A. Konstantinopoulos

Source: Gynecologic Oncology Reports, Vol 40, Iss , Pp 100974- (2022)

Subject Terms: Uterine serous carcinoma, MK-2206, AKT inhibitor, PI3K/AKT pathway, Gynecology and obstetrics, RG1-991, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2352578922000546; https://doaj.org/toc/2352-5789

Access URL: https://doaj.org/article/9a6dad8bf1b54f1fada0cfe8b5c09232

Evaluation of the incidence and clinical significance of WT-1 expression in uterine serous carcinoma

Authors: Jennifer McEachron, Agha Wajdan Baqir, Nancy Zhou, Absia Jabbar, Raavi Gupta, Daniel Levitan, Yi-Chun Lee

Source: Gynecologic Oncology Reports, Vol 39, Iss , Pp 100918- (2022)

Subject Terms: Uterine serous carcinoma, Wilms Tumor 1 gene, Gynecology and obstetrics, RG1-991, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2352578921002228; https://doaj.org/toc/2352-5789

Access URL: https://doaj.org/article/d82d99ebcba642fba45d00f0c4dc4aec

Optimal cytoreduction followed by chemoradiation in stage IVB uterine serous carcinoma

Authors: Jennifer McEachron, Nancy Zhou, Victoria Hastings, Michelle Bennett, Constantine Gorelick, Margaux J. Kanis, Yi-Chun Lee

Source: Cancer Treatment and Research Communications, Vol 33, Iss , Pp 100631- (2022)

Subject Terms: Uterine serous carcinoma, Chemotherapy, Radiation, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2468294222001228; https://doaj.org/toc/2468-2942

Access URL: https://doaj.org/article/4eaf368675c342208336762000acb401

Concomitant diagnosis of endometrial and breast cancer - does the sequence matters?

Authors: Tomer Stern, Shira Peleg Hasson, Akram Saad, Keren Levanon, Nadav Michaan, Ido Laskov, Ido Wolf, Dan Grisaru, Tamar Safra

Source: Gynecologic Oncology Reports, Vol 38, Iss , Pp 100863- (2021)

Subject Terms: Breast Cancer, Endometrial Cancer, Uterine serous carcinoma, BRCA, Tamoxifen, Gynecology and obstetrics, RG1-991, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2352578921001673; https://doaj.org/toc/2352-5789

Access URL: https://doaj.org/article/5286d35badc04d7fb74c2b7a8a947bc1